CCL
68
-4
CMS
67
3
CF
57
-3
HRL
30
-5
MCHP
43
-6
LMT
47
7
DNB
50
-4
CHD
54
6
ILMN
41
-3
BIIB
37
7
KMI
59
2
JBHT
50
-6
ADM
33
-3
MS
64
7
MSI
72
2
FIS
46
-4
EL
30
-3
PPL
65
6
BRK.B
42
-3
AN
50
-5
CCL
68
-4
CMS
67
3
CF
57
-3
HRL
30
-5
MCHP
43
-6
LMT
47
7
DNB
50
-4
CHD
54
6
ILMN
41
-3
BIIB
37
7
KMI
59
2
JBHT
50
-6
ADM
33
-3
MS
64
7
MSI
72
2
FIS
46
-4
EL
30
-3
PPL
65
6
BRK.B
42
-3
AN
50
-5
Financhill
Back

The Materials Select Sector SPDR® ETF Vs. Apellis Pharmaceuticals Industry Stock Comparison

Buy
60

XLB
The Materials Select Sector SPDR® ETF

Last Price:
94.10
Seasonality Move:
3.22%
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
32.49
Seasonality Move:
18.8%
Buy
60
The Materials Select Sector SPDR® ETF (XLB) is a Buy

Is The Materials Select Sector SPDR® ETF a Buy, Sell or Hold?

  • The current The Materials Select Sector SPDR® ETF [XLB] share price is $94.07. The Score for XLB is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • XLB is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

XLB Stock Price Chart

What is The Materials Select Sector SPDR® ETF's stock price today?

  • The The Materials Select Sector SPDR® ETF share price today is $94.07
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and XLB is experiencing slight selling pressure.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

XLB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.8 Buy
Relative Strength Index (14 RSI): 60.83 Buy
Chaikin Money Flow: -982416 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (90.94 - 93.56) Buy
Bollinger Bands (100): (88.86 - 92.24) Buy

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: -1084788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.37 - 40.01) Sell
Bollinger Bands (100): (36.55 - 42.35) Sell

XLB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 93.12 Buy
20-day SMA: 92.53 Buy
50-day SMA: 91.16 Buy
200-day SMA: 88.59 Buy
8-day EMA: 93.32 Buy
20-day EMA: 92.43 Buy
50-day EMA: 91.4 Buy
200-day EMA: 88.5 Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 38.04 Sell
50-day SMA: 37.88 Sell
200-day SMA: 50 Sell
8-day EMA: 35.96 Sell
20-day EMA: 37.21 Sell
50-day EMA: 38.25 Sell
200-day EMA: 45.7 Sell

The Materials Select Sector SPDR® ETF Earnings Growth & XLB Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

The Materials Select Sector SPDR® ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):